Advertisement
Screener

BIOMARIN PHARMACEUTICAL INC (BMRN) Analyst Insights

RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$56.00(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$56.00High(m)Average(m)Low(m)2025-11-062026-11-06
DateStockAnalystFirmPrice When RatedPrice TargetUpside / DownsideRatingPerformance
2026-08-17BMRN
BIOMARIN PHARMACEUTICAL INC
Yun ZhongWedbush Securities$67.36$94.00+39.55%Outperform
2026-08-14BMRN
BIOMARIN PHARMACEUTICAL INC
Eliana Merle, CFABarclays$68.53$111.00+61.97%Overweight
2026-03-03BMRN
BIOMARIN PHARMACEUTICAL INC
Eliana Merle, CFABarclays$61.73$105.00+70.10%Overweight
2025-10-28BMRN
BIOMARIN PHARMACEUTICAL INC
Eliana Merle, CFABarclays$52.67$80.00+51.89%Overweight
2024-10-03BMRN
BIOMARIN PHARMACEUTICAL INC
Eliana Merle, CFABarclays$68.16$86.00+26.17%Overweight
2024-08-06BMRN
BIOMARIN PHARMACEUTICAL INC
Eliana Merle, CFABarclays$80.47$110.00+36.70%Overweight
2023-11-02BMRN
BIOMARIN PHARMACEUTICAL INC
Eliana Merle, CFABarclays$84.01$111.00+32.13%Overweight

Similar stocks

Stock NameCountryMarket CapPE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05